
### [MONDO:0004689](http://purl.obolibrary.org/obo/MONDO_0004689)
**Label:** metal metabolism disorder

**Subclasses:** [MONDO:0016048](http://purl.obolibrary.org/obo/MONDO_0016048) (isolated autosomal dominant hypomagnesemia, Glaudemans type), [MONDO:0013234](http://purl.obolibrary.org/obo/MONDO_0013234) (hypokalemic periodic paralysis, type 2), [MONDO:0014225](http://purl.obolibrary.org/obo/MONDO_0014225) (hemochromatosis type 5), [MONDO:0018700](http://purl.obolibrary.org/obo/MONDO_0018700) (pseudohypoparathyroidism without Albright hereditary osteodystrophy), [MONDO:0009275](http://purl.obolibrary.org/obo/MONDO_0009275) (neonatal hemochromatosis), [MONDO:0009550](http://purl.obolibrary.org/obo/MONDO_0009550) (renal hypomagnesemia 3), [MONDO:0011012](http://purl.obolibrary.org/obo/MONDO_0011012) (african iron overload), [MONDO:0016363](http://purl.obolibrary.org/obo/MONDO_0016363) (rare hereditary hemochromatosis), [MONDO:0011176](http://purl.obolibrary.org/obo/MONDO_0011176) (intestinal hypomagnesemia 1), [MONDO:0018101](http://purl.obolibrary.org/obo/MONDO_0018101) (familial primary hypomagnesemia with normocalciuria and normocalcemia), [MONDO:0019257](http://purl.obolibrary.org/obo/MONDO_0019257) (hemochromatosis type 2), [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0019992](http://purl.obolibrary.org/obo/MONDO_0019992) (pseudohypoparathyroidism), [MONDO:0008224](http://purl.obolibrary.org/obo/MONDO_0008224) (hyperkalemic periodic paralysis), [MONDO:0018100](http://purl.obolibrary.org/obo/MONDO_0018100) (primary hypomagnesemia), [MONDO:0013193](http://purl.obolibrary.org/obo/MONDO_0013193) (thyrotoxic periodic paralysis, susceptibility to, 2), [MONDO:0008846](http://purl.obolibrary.org/obo/MONDO_0008846) (atransferrinemia), [MONDO:0008749](http://purl.obolibrary.org/obo/MONDO_0008749) (pseudohypoparathyroidism type 2), [MONDO:0010200](http://purl.obolibrary.org/obo/MONDO_0010200) (Wilson disease), [MONDO:0011631](http://purl.obolibrary.org/obo/MONDO_0011631) (hemochromatosis type 4), [MONDO:0011417](http://purl.obolibrary.org/obo/MONDO_0011417) (hemochromatosis type 3), [MONDO:0011216](http://purl.obolibrary.org/obo/MONDO_0011216) (hemochromatosis type 2A), [MONDO:0014631](http://purl.obolibrary.org/obo/MONDO_0014631) (hypomagnesemia, seizures, and mental retardation), [MONDO:0018699](http://purl.obolibrary.org/obo/MONDO_0018699) (pseudohypoparathyroidism with Albright hereditary osteodystrophy), [MONDO:0017624](http://purl.obolibrary.org/obo/MONDO_0017624) (familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis), [MONDO:0008570](http://purl.obolibrary.org/obo/MONDO_0008570) (thyrotoxic periodic paralysis, susceptibility to, 1), [MONDO:0019201](http://purl.obolibrary.org/obo/MONDO_0019201) (thyrotoxic periodic paralysis), [MONDO:0013220](http://purl.obolibrary.org/obo/MONDO_0013220) (hemochromatosis type 2B), [MONDO:0013480](http://purl.obolibrary.org/obo/MONDO_0013480) (renal hypomagnesemia 6), [MONDO:0007937](http://purl.obolibrary.org/obo/MONDO_0007937) (renal hypomagnesemia 2), [MONDO:0009548](http://purl.obolibrary.org/obo/MONDO_0009548) (renal hypomagnesemia 5 with ocular involvement), [MONDO:0008713](http://purl.obolibrary.org/obo/MONDO_0008713) (acrodermatitis enteropathica), [MONDO:0013908](http://purl.obolibrary.org/obo/MONDO_0013908) (TTPP3), [MONDO:0012717](http://purl.obolibrary.org/obo/MONDO_0012717) (renal hypomagnesemia 4), [MONDO:0007078](http://purl.obolibrary.org/obo/MONDO_0007078) (Albright's hereditary osteodystrophy), [MONDO:0010651](http://purl.obolibrary.org/obo/MONDO_0010651) (Menkes disease), [MONDO:0011301](http://purl.obolibrary.org/obo/MONDO_0011301) (pseudohypoparathyroidism type 1B), [MONDO:0017626](http://purl.obolibrary.org/obo/MONDO_0017626) (familial primary hypomagnesemia with normocalcuria), [MONDO:0017625](http://purl.obolibrary.org/obo/MONDO_0017625) (familial primary hypomagnesemia with hypocalcuria), [MONDO:0012912](http://purl.obolibrary.org/obo/MONDO_0012912) (pseudopseudohypoparathyroidism), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), 

**Corr. equiv. classes:** [Orphanet:682](http://www.orpha.net/ORDO/Orphanet_682), [OMIM:611718](http://purl.obolibrary.org/obo/OMIM_611718), [Orphanet:681](http://www.orpha.net/ORDO/Orphanet_681), [OMIM:188580](http://purl.obolibrary.org/obo/OMIM_188580), [Orphanet:37](http://www.orpha.net/ORDO/Orphanet_37), [Orphanet:199326](http://www.orpha.net/ORDO/Orphanet_199326), [OMIM:231100](http://purl.obolibrary.org/obo/OMIM_231100), [OMIM:248250](http://purl.obolibrary.org/obo/OMIM_248250), [OMIM:613345](http://purl.obolibrary.org/obo/OMIM_613345), [Orphanet:306516](http://www.orpha.net/ORDO/Orphanet_306516), [Orphanet:457062](http://www.orpha.net/ORDO/Orphanet_457062), [Orphanet:306519](http://www.orpha.net/ORDO/Orphanet_306519), [Orphanet:79230](http://www.orpha.net/ORDO/Orphanet_79230), [OMIM:103580](http://purl.obolibrary.org/obo/OMIM_103580), [OMIM:614834](http://purl.obolibrary.org/obo/OMIM_614834), [OMIM:277900](http://purl.obolibrary.org/obo/OMIM_277900), [OMIM:616418](http://purl.obolibrary.org/obo/OMIM_616418), [Orphanet:139507](http://www.orpha.net/ORDO/Orphanet_139507), [OMIM:601195](http://purl.obolibrary.org/obo/OMIM_601195), [Orphanet:94090](http://www.orpha.net/ORDO/Orphanet_94090), [Orphanet:447792](http://www.orpha.net/ORDO/Orphanet_447792), [Orphanet:139491](http://www.orpha.net/ORDO/Orphanet_139491), [OMIM:170500](http://purl.obolibrary.org/obo/OMIM_170500), [OMIM:612462](http://purl.obolibrary.org/obo/OMIM_612462), [OMIM:612463](http://purl.obolibrary.org/obo/OMIM_612463), [OMIM:613313](http://purl.obolibrary.org/obo/OMIM_613313), [Orphanet:905](http://www.orpha.net/ORDO/Orphanet_905), [Orphanet:94089](http://www.orpha.net/ORDO/Orphanet_94089), [OMIM:602390](http://purl.obolibrary.org/obo/OMIM_602390), [OMIM:613239](http://purl.obolibrary.org/obo/OMIM_613239), [Orphanet:31043](http://www.orpha.net/ORDO/Orphanet_31043), [Orphanet:79102](http://www.orpha.net/ORDO/Orphanet_79102), [OMIM:604250](http://purl.obolibrary.org/obo/OMIM_604250), [OMIM:603233](http://purl.obolibrary.org/obo/OMIM_603233), [Orphanet:97593](http://www.orpha.net/ORDO/Orphanet_97593), [OMIM:201100](http://purl.obolibrary.org/obo/OMIM_201100), [Orphanet:247790](http://www.orpha.net/ORDO/Orphanet_247790), [OMIM:248190](http://purl.obolibrary.org/obo/OMIM_248190), [OMIM:613882](http://purl.obolibrary.org/obo/OMIM_613882), [OMIM:203330](http://purl.obolibrary.org/obo/OMIM_203330), [Orphanet:225123](http://www.orpha.net/ORDO/Orphanet_225123), [Orphanet:1195](http://www.orpha.net/ORDO/Orphanet_1195), [OMIM:606069](http://purl.obolibrary.org/obo/OMIM_606069), [OMIM:602014](http://purl.obolibrary.org/obo/OMIM_602014), [Orphanet:34527](http://www.orpha.net/ORDO/Orphanet_34527), [Orphanet:34526](http://www.orpha.net/ORDO/Orphanet_34526), [Orphanet:34528](http://www.orpha.net/ORDO/Orphanet_34528), [OMIM:154020](http://purl.obolibrary.org/obo/OMIM_154020), [OMIM:309400](http://purl.obolibrary.org/obo/OMIM_309400), [Orphanet:457059](http://www.orpha.net/ORDO/Orphanet_457059), [Orphanet:30924](http://www.orpha.net/ORDO/Orphanet_30924), [OMIM:170400](http://purl.obolibrary.org/obo/OMIM_170400), [Orphanet:306522](http://www.orpha.net/ORDO/Orphanet_306522), [OMIM:209300](http://purl.obolibrary.org/obo/OMIM_209300), [Orphanet:2196](http://www.orpha.net/ORDO/Orphanet_2196), [OMIM:615517](http://purl.obolibrary.org/obo/OMIM_615517), [Orphanet:220489](http://www.orpha.net/ORDO/Orphanet_220489), [Orphanet:565](http://www.orpha.net/ORDO/Orphanet_565), [Orphanet:79443](http://www.orpha.net/ORDO/Orphanet_79443), [Orphanet:79444](http://www.orpha.net/ORDO/Orphanet_79444), [Orphanet:79445](http://www.orpha.net/ORDO/Orphanet_79445), [Orphanet:446](http://www.orpha.net/ORDO/Orphanet_446), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 39.71%
- Thing 39.70%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 39.70%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 37.46%
- [HP:0010927](http://purl.obolibrary.org/obo/HP_0010927) (Abnormality of divalent inorganic cation homeostasis) and (not ([HP:0003072](http://purl.obolibrary.org/obo/HP_0003072) (Hypercalcemia))) 35.09%
- [HP:0010927](http://purl.obolibrary.org/obo/HP_0010927) (Abnormality of divalent inorganic cation homeostasis) and (not ([HP:0011843](http://purl.obolibrary.org/obo/HP_0011843) (Abnormality of skeletal physiology))) 33.92%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 27.93%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 25.21%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 24.07%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 22.92%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 22.17%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 21.72%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 21.02%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 20.38%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 17.57%


